Charles Schwab
JUNO

Charles Schwab’s Juno Therapeutics, Inc. JUNO Stock Holding History

Charles Schwab’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-378,195
Closed -$17.3M – 3088
2017
Q4 		$17.3M Buy
378,195
+53,821
+17% +$2.68M 0.01% 1090
2017
Q3 		$14.6M Buy
324,374
+54,418
+20% +$1.86M 0.01% 1152
2017
Q2 		$8.07M Sell
269,956
-17,148
-6% -$423K 0.01% 1495
2017
Q1 		$6.37M Buy
287,104
+17,758
+7% +$381K 0.01% 1609
2016
Q4 		$5.08M Buy
269,346
+29,306
+12% +$717K 0.01% 1731
2016
Q3 		$7.2M Buy
240,040
+5,592
+2% +$174K 0.01% 1402
2016
Q2 		$9.01M Buy
234,448
+21,711
+10% +$901K 0.01% 1148
2016
Q1 		$8.1M Buy
212,737
+28,229
+15% +$984K 0.01% 1187
2015
Q4 		$8.11M Buy
184,508
+23,068
+14% +$1.14M 0.01% 1157
2015
Q3 		$6.57M Buy
161,440
+104,777
+185% +$4.6M 0.01% 1293
2015
Q2 		$3.02M Buy
56,663
+11,550
+26% +$613K ﹤0.01% 1864
2015
Q1 		$2.74M Buy
+45,113
New +$2.19M ﹤0.01% 1885

Other funds holding JUNO

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Charles Schwab's JUNO Position: Q1 2018 in Review

Charles Schwab sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 378,195 shares — an estimated $17.3M sold.

Charles Schwab first reported a position in JUNO in Q1 2015 and held it in 12 quarters. The position peaked at $17.3M in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

  • Charles Schwab reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • Charles Schwab sold 378,195 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $17.3M.
  • Charles Schwab first reported a position in Juno Therapeutics, Inc. in Q1 2015 and held it in 12 quarters.
  • Charles Schwab's Juno Therapeutics, Inc. position peaked at $17.3M in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Charles Schwab's 13F filing for Q1 2018, filed 7 May 2018.